Form 4 for EW Edwards Lifesciences
Accepted 2026-03-02 00:00:00 ET · period of report 2026-03-02 · accession 0001225208-26-002878 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-02 | 2026-03-02 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $85.93 | -11.3K | 21.3K | -35% | -$974.4K |
| D | 2026-03-02 | 2026-03-02 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $59.26 | +11.3K | 32.6K | +53% | +$672.0K |
| D | 2026-03-02 | 2026-03-02 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $0.00 | -11.3K | 22.7K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | S | D | 11,340 | $85.93 | 21,266.25 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $85.665 to $86.380. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2026-03-02 | M | A | 11,340 | $59.26 | 32,606.25 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2026-03-02 | M | D | 11,340 | $0.00 | 22,680 | D | $59.26 · 2019-06-08 to 2026-05-07 | 11,340 Common Stock |